Drugs / Botulium Toxin Type A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04572516 | May 2020 → Jun 2021 | chronic rhinosinusitis | Benha University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Botulium Toxin Type A | “Botulium Toxin Type A In Non Infectious Chronic Rhinosinusitis” NCT04572516 ↗ |
| Known as | BTX\_A | “20 units of BTX\_A (2ml) will be placed at each side of the nasal cavity” NCT04572516 ↗ |
| Route | Topical | “topical application in the form of merocel soaked with 20 units” NCT04572516 ↗ |